Sirona Biochem (SBM) Stock Price, News & Analysis

Company Overview

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.07 to C$0.08
• 50-Day Range: C$0.05 to C$0.08
• 52-Week Range: C$0.02 to C$0.12
• Volume: 96,999 shs
• Average Volume: 78,281 shs
• Market Capitalization: C$20.55 million
• P/E Ratio: N/A
• Dividend Yield: 1.50%
• Price Target: N/A
• Consensus Rating: N/A

SBM Stock Analysis - Frequently Asked Questions

How have SBM shares performed this year?

Sirona Biochem's stock was trading at C$0.12 at the beginning of 2024. Since then, SBM stock has decreased by 33.3% and is now trading at C$0.08.
View the best growth stocks for 2024 here.

How do I buy shares of Sirona Biochem?

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Sirona Biochem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Neovasc (NVCN) and Sorrento Therapeutics (SRNE).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:SBM
• CUSIP: N/A
• CIK: N/A
• Web: www.sironabiochem.com
• Phone: 604-641-4466
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-2,670,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -9,810.47%
• Return on Assets: -148.11%

Debt

• Debt-to-Equity Ratio: 219.21
• Current Ratio: 0.34
• Quick Ratio: 2.41

Sales & Book Value

• Annual Sales: C$683,768.00
• Price / Sales: 30.05
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 35.00
• Book Value: C($0.01) per share
• Price / Book: -8.00

Miscellaneous

• Outstanding Shares: 256,820,000
• Free Float: N/A
• Market Cap: C$20.55 million
• Optionable: Not Optionable
• Beta: -0.03